Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial.

Authors :: Zilli T
Franzese C
Bottero M
Giaj-Levra N
Förster R
Zwahlen D
Koutsouvelis N
Bertaut A
Blanc J
Roberto D'agostino G
Alongi F
Guckenberger M
Scorsetti M
Miralbell R
Source :: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2019 Oct; Vol. 139, pp. 83-86. Date of Electronic Publication: 2019 Aug 17.
Publication Year :: 2019
Abstract: The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.<br /> (Copyright © 2019 Elsevier B.V. All rights reserved.)

Subjects :: Aged
Aged, 80 and over
Humans
Male
Prospective Studies
Prostatic Neoplasms radiotherapy
Radiosurgery methods
Radiotherapy, Image-Guided methods
Urethra radiation effects

Language :: English
ISSN :: 1879-0887
Volume :: 139
Database :: MEDLINE
Journal :: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Publication Type :: Academic Journal
Accession number :: 31431369
Full Text :: https://doi.org/10.1016/j.radonc.2019.07.018

Full Text Access

Tools